Prognostic Value of Plasma EBV DNA for Nasopharyngeal Cancer Patients during Treatment with Intensity-modulated Radiation Therapy and Concurrent Chemotherapy.

Lertbutsayanukul, Chawalit; Kannarunimit, Danita; Prayongrat, Anussara; Chakkabat, Chakkapong; Kitpanit, Sarin; Hansasuta, Pokrath

Lertbutsayanukul, Chawalit; Kannarunimit, Danita; Prayongrat, Anussara; Chakkabat, Chakkapong; Kitpanit, Sarin; Hansasuta, Pokrath.

Affiliation

Lertbutsayanukul C; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Kannarunimit D; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Prayongrat A; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Chakkabat C; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Kitpanit S; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Hansasuta P; Division of Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Radiol Oncol ; 52(2): 195-203, 2018 Jun.

Article in En | MEDLINE | ID: mdl-30018524

Key words

IMRT; Prognosis during treatment; nasopharyngeal cancer; plasma EBV

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Radiol Oncol Year: 2018 Document type: Article Affiliation country: Thailand Country of publication: Poland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google